PRESS RELEASE published on 02/03/2026 at 07:25, 2 months ago Elevating Trust: Fox ESS Grand Gala 2026 Welcomes Over 300 Global Partners Fox ESS hosted the Grand Gala 2026, welcoming over 300 global partners to explore clean energy and strengthen collaborations. Remarkable growth and market achievements Sustainable Future Clean Energy Global Partnerships Fox ESS Grand Gala 2026
PRESS RELEASE published on 02/03/2026 at 07:15, 2 months ago Sartorius Stedim Biotech réalise une croissance rentable importante en 2025 et maintient des perspectives positives Sartorius Stedim Biotech réalise une croissance rentable en 2025 avec un chiffre d'affaires en hausse de 9,6 %. Perspectives positives pour 2026 Chiffre D'affaires Sartorius Stedim Biotech Croissance Rentable Perspectives 2026
PRESS RELEASE published on 02/03/2026 at 07:00, 2 months ago Siltronic AG with preliminary financial figures: Targets for 2025 achieved despite challenging conditions Siltronic AG achieves 2025 targets with preliminary financial figures despite challenging conditions. Sales at EUR 1,347 million with 4.7% decline. EBITDA margin reaches 23.5% EBITDA Margin Preliminary Financial Figures Sales Decline Siltronic AG 2025 Targets
PRESS RELEASE published on 02/03/2026 at 07:00, 2 months ago Sartorius Stedim Biotech réalise une croissance rentable importante en 2025 et maintient des perspectives positives Sartorius Stedim Biotech réalise une croissance rentable en 2025 et maintient des perspectives positives. Chiffre d'affaires en hausse de 9,6% à taux de change constants. EBITDA à 914 millions d'euros. Perspectives de croissance rentable pour 2026 Chiffre D'affaires EBITDA Sartorius Stedim Biotech Croissance Rentable Perspectives Positives
PRESS RELEASE published on 02/03/2026 at 07:00, 2 months ago Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook Sartorius Stedim Biotech achieves significant profitable growth in 2025 with unaudited sales revenue up 9.6% in constant currencies. Management expects continued growth in 2026 Financial Results Sartorius Stedim Biotech Profitable Growth 2025 2026
PRESS RELEASE published on 02/03/2026 at 07:00, 2 months ago Medacta Group SA: Medacta Group reports continued significant above-market revenue growth of 18.5% in constant currency in 2025 Medacta Group SA reports 18.5% revenue growth in 2025, with strong performance in all geographic markets and business lines. New jobs created to drive further expansion Revenue Growth Business Lines Medacta Group SA 2025 Geographic Markets
PRESS RELEASE published on 02/03/2026 at 07:00, 2 months ago Sartorius achieves considerable profitable growth in 2025 and maintains positive outlook Sartorius achieves considerable profitable growth in 2025 with a 7.6% increase in sales revenue to around 3.5 billion euros. Positive outlook maintained for 2026 Sartorius Profitable Growth Sales Revenue Positive Outlook 2026
PRESS RELEASE published on 02/03/2026 at 07:00, 2 months ago Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia Newron Pharmaceuticals S.p.A. announces publication highlighting Evenamide as adjunctive treatment in schizophrenia. Scientific evidence supports unique approach Schizophrenia Publication Newron Pharmaceuticals Evenamide Adjunctive Treatment
PRESS RELEASE published on 02/03/2026 at 07:00, 2 months ago AT&S records positive net profit again in the third quarter AT&S reports positive net profit again in Q3 of 2025/26, with revenue up 10%. CEO Michael Mertin optimistic about operational progress & market environment Revenue Market Environment AT&S Net Profit Q3 2025/26
Published on 04/02/2026 at 22:00, 20 hours 48 minutes ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 1 day ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 3 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 4 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 4 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/03/2026 at 18:00, 48 minutes ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 48 minutes ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 1 hour 3 minutes ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 17:40, 1 hour 8 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.04.26.
Published on 04/03/2026 at 17:05, 1 hour 43 minutes ago At WMF a new edition of AI Global Summit, an international reference point on Artificial Intelligence
Published on 04/03/2026 at 18:01, 46 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 48 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 48 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
Published on 04/03/2026 at 18:00, 48 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 48 minutes ago ALTAREA : Déclaration d’opérations sur actions propres